Show Notes
In this podcast, Emma Sutherland is joined by psychophysiologist and Monash University researcher Dr Simone Peters - one of the world’s leading experts in gut-directed hypnotherapy - to explore the rise of this behavioural therapy as a first-line treatment for IBS and other gut disorders.
From her landmark randomised controlled trial (RCT) comparing hypnotherapy to the low fermentable, oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet, to the development of the Nerva app, Simone presents compelling data on how this therapy works, with 75–80% of patients responding within six weeks.
The recommendation to use gut-directed hypnotherapy for IBS now forms international treatment guidelines and this episode empowers practitioners to integrate mind-body approaches into clinical care for IBS and beyond.
Covered in this episode:
(01:04) Welcome Simone Peters
(06:04) Hypnotherapy and gut conditions
(08:04) Nerva app
(13:36) Patient experience
(17:35) IBS, males vs females
(20:00) Drivers behind IBS
(22:38) Psychogastroenterology
(25:53) Research in gut-directed hypnotherapy
(29:44) Dr Peters research
(36:50) Who is it for?
(39:26) Synergistic modalities
(43:33) Future of gut-directed hypnotherapy
(46:33) Final remarks
Find today's transcript and show notes here: https://www.bioceuticals.com.au/education/podcasts/gut-directed-hypnotherapy
Sign up for our monthly newsletter for the latest exclusive clinical tools, articles, and infographics: www.bioceuticals.com.au/signup/
DISCLAIMER: The information provided on fx Medicine by BioCeuticals is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you learn here raises questions or concerns regarding your health.
More from FX Medicine Podcast Central
In this podcast episode, Emma Sutherland speaks with Dr Nick Fuller, Clinical Trials Director at the Royal Prince Alfred Hospital Endocrinology Department and researcher at the Charles Perkins Centre. Together they unpack the complex physiology behind weight regain, including metabolic adaptation, appetite-hormone shifts, and the evolutionary mechanisms that make long-term weight loss so challenging.
Dr Stacy Sims, expert in female physiology and training, collaborates with fx Ambassador Lisa Costa-Bir to discuss the intricate relationship between hormones and physical performance.
Jane Hutchens, naturopath and reproductive health and human genetics expert, along with fx Medicine ambassador, Emma Sutherland, raise awareness on the importance of understanding cardiovascular health implications during pregnancy and post-partum. This impacts 1 to 4 percent of women in Australia and is under recognized and underreported.
In part two of our Perspectives podcast, fx Medicine by BioCeuticals ambassadors Lisa Costa-Bir, Dr Michelle Woolhouse, Mick Alexander and Dr Adrian Lopresti, join host Emma Sutherland to explore practical, evidence-aligned treatment strategies for patients with cardiometabolic dysfunction. The discussion covers GLP-1 receptor agonists (GLP-1 RAs) including side effect management and dietary and lifestyle support. They also discuss the evolving landscape of new cardiometabolic medications, and the behavioural, psychological, and social factors that shape long-term cardiometabolic outcomes.
In this insightful conversation, naturopathic doctor and bestselling author Lara Briden joins Emma Sutherland to explore androgen physiology, excess, and sensitivity in women. Together they discuss the complexities of diagnosing androgen excess, including polycystic ovarian syndrome (PCOS) and adrenal-driven cases, and examine the metabolic consequences of chronically elevated androgens. They discuss the challenging clinical presentation of female pattern hair loss or androgenic hair loss talking about cause and realistic treatments.